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Summary The QR regressor tumour (QR-32), a fibrosarcoma which is unable to grow progressively in
normal syngeneic C57BL/6 mice, was able to grow progressively in 13 out of 22 mice (59%) when it was
subcutaneously coimplanted with gelatin sponge. We established four culture tumour lines from the resultant
tumours (QRsP tumour lines). These QRsP tumour lines were able to grow progressively in mice even in the
absence of gelatin sponge. The ability of QRsP tumour cells to colonise the lungs after intravenous injection
and to produce high amounts of prostaglandin E2 (PGE2) during in vitro cell culture was much greater than
that of parent QR-32 cells. These biological characteristics of QR-32 cells and QRsP tumour cells were found
to be stable for at least 6 months when they were maintained in culture.
We also observed that QR-32 cells were able to grow progressively in five out of 12 (42%) mice after
coimplantation with plastic non-adherent peritoneal cells obtained from mice which had been intra-
peritoneally implanted with gelatin sponge. These host cells reactive to gelatin sponge increased the production
of high amounts of PGE2 by QR-32 cells during 48 h coculture. Preliminary in vitro studies implicated the
involvement of hydrogen peroxide and hydroxyl radical as some of the factors necessary to induce QR-32 cells
to produce high amounts of PGE2 and to accelerate tumour progression.
The lack of suitable experimental models for investigation of
tumour progression limits the in vivo screening of tumour-
progressing factors. We established a cultured clone (QR-32)
of a mouse fibrosarcoma which is difficult to grow in normal
syngeneic C57BL/6 mice (Ishikawa et al., 1987a; Okada et
al., 1990). We have attempted to promote the growth of
QR-32 cells in normal mice by their coimplantation with
foreign bodies such as plastic plate or gelatin sponge, since
previous reports show that glass beads or plastic plates
induce non-tumorigenic Balb/3T3 cells to grow in syngeneic
mice (Boone, 1975; Boone et al., 1979). Similarly, in our
experiments, we have observed that foreign bodies can pro-
mote QR-32 tumour growth in normal mice. We have
therefore studied whether or not cells from the resultant
tumours exhibit altered biological characteristics such as in
vivo tumorigenicity, lung colonising capacity and in vitro
production of prostaglandin E2 (PGE2), when compared with
parent QR-32 cells. In this report, we present the results of
experiments in which we investigated the malignant proper-
ties of tumours that develop in vivo after the coimplantation
of QR-32 cells with either gelatin sponge or peritoneal
exudate cells reactive to gelatin sponge. We also analysed
that feature of the mechanism responsible for promoting the
effects of gelatin sponge on the in vivo growth of QR-32 cells;
our preliminary results indicate a role for oxygen radicals in
the malignant progression of this regressor tumour.
Materials and methods
Animals
Female C57BL/6 mice between 2 and 4 months of age were
obtained from Clea Japan, Inc.
Tumour
The origin and characteristics of the tumour cells used in this
experiment have been described previously (Ishikawa et al.,
1987a,b; Okada et al., 1990). Briefly, BMT-1 is a transplan-
table mouse fibrosarcoma, which is induced by 3-methyl-
cholanthrene in a C57BL/6 mouse (Ishikawa et al., 1987b).
We then first isolated culture lines of BMT-1 1 and its clone,
BMT-1 cl-9. After exposure of the tumorigenic BMT-l cl-9
cells to quercetin and cloning procedures, we obtained a
number of clones which spontaneously regressed in normal
syngeneic hosts, and were subsequently named QR clones
(Ishikawa et al., 1987a). QR clones exhibit regression in mice
after challenge with 2 x 105 cells, a dose that is four times
greater than the minimum take dose of the BMT-l cl-9 and
is defined as weakly tumorigenic (Ishikawa et al., 1987a;
Okada et al., 1990). Since these tumour cells have been
maintained in culture for over 5 years after the establishment
of the cell line, we consider that these tumour cells, which we
used throughout our experiments, do not exhibit any normal
host cell contamination.
We have previously reported that QR clones grew progres-
sively when they were injected into mice which had been
irradiated and/or treated with monoclonal antibodies for
mouse T helper cells. Not only QR clones but also their
variant progressor clones were equally immunogenic in mice
because cytotoxic T lymphocytes (CTLs) were equally
inducible from mice which have been immunised with the
corresponding irradiated tumours (Okada et al., 1990). The
regression of QR-32 cells is mainly due to the decrease in the
production of prostaglandin E2 (PGE2), which suppresses
antitumour effector cell induction at the site of tumour
implantation (Okada et al., 1990). This finding is supported
by the fact that the subcutaneous growth of high-PGE2-
producing progressor clones in mice was markedly inhibited
after oral administration of the PGE2 synthesis inhibitor
indomethacin (Okada et al., 1990).
In our previous study (Okada et al., 1990), we found that
the threshold value of PGE2-production required to suppress
host immune reactivity in vivo was approximately 6,000 pg-
ml-', a value which in vitro is produced either by 1 x 105
tumour cells during 24 h culture or by 1 x 104 tumour cells
during 48 h culture.
Measurement ofin vivo growth of tumours
In this study we have used the weakly malignant clonal
QR-32 cells to define tumour progression as the conversion
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of tumour cells to a more malignant phenotype that exhibits
such properties as acquired tumorigenicity, invasive and
metastasising power and, ultimately, the ability to kill the
host more rapidly. We therefore observed the tumour-bearing
mice until they died of the tumour because the mean survival
times and the spontaneous metastasis to distant organs are
important parameters for confirming tumour progression and
need to be monitored right to the end.
Mouse survival was observed up to 100 days after tumour
implantation. Four of the tumours that resulted from coimp-
lanted with gelatin sponge were cultured separately, and were
named QRsP-1, -2, -3 and -4 tumour lines. Since these QRsP
tumour lines were cultured for at least two weeks and
involved more than four subcultures during this period, the
QRsP tumour lines were uncontaminated with any (or neg-
ligible) host cells.
Culture conditions
The QR-32 cells and QRsP tumour lines were maintined as a
monolayer culture. Host cells were maintained as a suspen-
sion culture. All tumour cells and host cells were cultured in
Eagle's minimum essential medium that contained 8% fetal
calf serum (inactivated at 56°C for 30 min), sodium pyruvate,
non-essential amino acids and L-glutamine, at 37°C, in a
humidified 5% C02/95% air mixture.
QR-32 cells and QRsP tumour lines were grown con-
tinuously under the following normal culture conditions.
Tumour cells (2.5 x 105/flask) were individually plated into
25 cm2 tissue culture flasks (Corning 25100) in 6 ml of the
culture medium. The medium was changed every other day
and, under these conditions, tumour cells grew to a confluent
state in 4 to 5 days after plating. Tumour cells were detached
with 0.02% EDTA, and 2.5 x 105 cells were subcultured.
Tumour cells were maintained for long-term culture under
the same conditions. Under these culture conditions, no
significant changes in tumour growth rates and doubling
times (between 18 to 20 h) were observed.
As compared with untreated QR-32 and untreated gelatin
sponge-reactive cells, no changes were seen to take place in
cell viabilities in the presence of radical scavengers (SOD,
300 Uml-'; catalase, 20,000ml'; mannitol, 5 x 10-2M)
when exposed for 48 h. These concentrations have been refer-
red to in a previous report (Yamashina et al., 1986).
Proceduresfor coimplantation ofQR cells with gelatin sponge
Sterile gelatin sponges (Spongel, Yamanouchi Pharm. Co.
Ltd., Japan), were cut into 10 x 5 x 3 mm sections. Mice
were anesthetised with ether and after their backs had been
swabbed with 70% alcohol, an approximately 10 mm-incision
was made in the skin of each mouse on the right flank of the
pelvic region. A pocket reaching up to the thorax was made
under the skin with the tip ofa sterilised scissors. One section
of gelatin sponge was inserted under the skin away from the
wound, and the wounds were closed with sterile clips. QR-32
cells (1 x 105/0.1 ml) were then injected into the pre-inserted
gelatin sponge. Tumours developed at the site of gelatin
sponge implantation, and not at the wound site. In no in-
stances were tumours observed at wound sites. Average
tumour diameters were measured twice weekly with vernier
calipers.
Preparation ofgelatin sponge-reactive cells
After the mice has been anesthetised, their abdomens were
swabbed with alcohol and an approximately 10 mm-cut was
made in the skin of each mouse. An 8 mm-cut was made in
the peritoneum of each mouse, and one section of gelatin
sponge (10 x 5 x 3 mm) was inserted per mouse. The wounds
in the peritoneum were closed with a suture, and the skin
was closed with sterile clips. Peritoneal exudate cells (PEC)
were harvested 5 days later by lavage of the peritoneal cavity
after injection of 5 ml sterile ice-cold 0.85% NaCl supp-
lemented with penicillin G (200 u ml') and heparin sodium
(1OU ml'), followed by aspiration of the fluid with a syr-
inge using a 23-gauge needle. This procedure was repeated
twice. After erythrocyte lysis with TRIS-buffered ammonium
chloride, the remaining viable cells in the medium were
seeded into plastic dishes and incubated for 1 h.
Thereafter, non-adherent cells were collected and used as
gelatin sponge-reactive cells. If we had used plastic adherent
cells, we would not have been able to observe any alterna-
tions in the PGE2-production by QR-32 cells since adherent
cells themselves produce high amounts of PGE2. Histological
examination of the cellular subpopulations within the gelatin
sponge-reactive cells indicated that these were composed of
65% lymphocytes, 20% polymorphonuclear cells, 15%
macrophages. Gelatin sponge-reactive cells have a very weak
cytolytic effect on QR-32 cells. Specific cytolysis of Indium-
111-oxine-labelled QR-32 cells after 48 h incubation was only
13.9%, even at an E:T ratio of 100:1.
Experimentalpulmonary metastasis
Normal C57BL/6 mice were intravenously injected with
1 x 106 cells in 0.2 ml serum-free MEM medium, and
sacrificed 19 days later. The lungs were fixed with Bouin's
solution, and the macroscopical metastatic nodules on the
lung surface were counted. Neither QR-32 cells nor QRsP-
1-4 tumour lines produced any macroscopical metastatic
nodules on the surface of the liver, spleen or kidney.
Preparation ofsupernatantsfor measuring PGE2
Viable QR-32 cells (1 x 104) were cultured with gelatin
sponge-reactive cells (1 x 105 or 1 x 106) in 24-well plastic
plates in 2 ml of medium per well. The supernatants were
stored below - 70°C until assay for PGE2.
Chemicals
Penicillin G was obtained from Meiji Pharm. Co., Ltd.,
(Tokyo, Japan). Heparin sodium was obtained from Kodama
Co., Ltd., (Tokyo, Japan). Recombinant human superoxide
dismutase (SOD) was supplied by Nippon Kayaku Co., Ltd.,
(Tokyo, Japan), while catalase, mannitol and indomethacin
were obtained from Sigma (St Louis, MO).
Radioimmunoassayfor PGE2
The amount of prostaglandin E2 (PGE2) secreted by tumour
and host cells during cell culture was measured by a commer-
cially available radioimmunoassay kit (New England Nu-
clear, Boston, Mass). The details of this assay have already
been described elsewhere (Okada et al., 1990).
Statistical analysis
All studies were repeated two or three times and the tables
represent data obtained in one out of at least two
experiments with similar results. The significance of the
difference in tumour incidence was calculated by a x2 test and
the difference in the number of lung colonies was calculated
by a Student's t-test.
Results
Growth ofQR-32 cells in syngeneic mice after coimplantation
with gelatin sponge
QR-32 cells exhibits spontaneous regression in normal mice
even after subcutaneous challenge with 1 x 105 cells. As
Table I shows, QR-32 cells which had been coimplanted with
gelatin sponge grew progressively in five out of ten animals in
Exp.1 (50%) and eight out of 12 animals in Exp.2 (67%,
P<0.05), a total of 13 animals out of 22 (59%, P<0.002).
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Table I Growth of QR-32 cells in syngeneic C57BL/6 mice after
coimplantation with gelatin sponge
Tumorigenicity (Died/used)
Implantation
witha Exp.l Exp.2 Total (%)
Gelatin sponge 5/10 8/12b 13/22C (59)
None 0/5 0/8 0/13 (0)
aOne x 105 ofQR-32 cells were coimplanted with or without gelatin
sponge (10 x 5 x 3 mm) into the back of normal C57BL/6 mice. b
P<0.05, c P<0.002 versus animals injected with QR-32 cells alone.
arose in mice after s.c. coimplantation of QR-32 cells with
gelatin sponge; we named these lines QRsP-1, -2, -3 and -4.
Tumorigenicity and PGE2-production by QR-32 cells and
QRsP tumour lines
As Table II shows, we next compared the biological charac-
teristics of these established tumour lines with the original
QR-32 cells. To avoid any normal host cell contamination,
we used QRsP tumour lines after at least 2 weeks in vitro cell
culture that involved subcultures derived more than four
times. We observed that QRsP-2, -3 and -4 tumour lines
produced significantly higher amounts of prostaglandin E2
(PGE2) than the QR-32 cells during in vitro cell culture, and
this appeared to correspond with the acquisition of in vivo
tumorigenicity in the QRsP-2, 3, 4 tumour lines (P<0.01,
P<0.05 and P<0.01, respectively), even in the absence of
gelatin sponge. Although no spontaneous lung metastasis
was observed when QR-32 cells and tumour lines QRsP-l to
-4 were injected s.c. into normal mice, QRsP tumour lines
showed significantly increased lung colonising ability after
i.v. injection as compared with parent QR-32 cells. PGE2-
production by the QRsP-l tumour line was only slightly
increased over that of the parent QR-32 cells and correlated
with weak tumorigenicity when injected subcutaneously, but
lung colonisation was significantly increased (P<0.001)
when the QRsP-l tumour line was injected intravenously.
Table III shows that biological characteristics such as in
vivo tumorigenicity after s.c. injection of QRsP tumour lines,
in vivo tumorigenicity of the QR-32 cells as well as the in
vitro PGE2-production of both cell types remained stable for
up to 6 months when cells were maintained under normal
culture conditions (See Materials and methods). No
Table III Stability ofthe biological characteristics ofQR-32 cells and
QRsP tumour lines during long-term culture
Cells maintained in culturefor:
Cells 0 months I month 3 months 6 months
In vivo tumorigenicity (Died mice/mice used)b
QR-32 0/8 0/5 0/5 0/5
QRsP-I 2/5 1/5 1/5 1/5
QRsP-2 5/5 5/5 5/5 5/5
QRsP-3 3/5 5/5 5/5 5/5
QRsP-4 5/5 5/5 5/5 5/5
In vitro PGE2-production by tumour cells (pg ml-')C
QR-32 1,600 1,400 1,600 1,800
QRsP-1 2,250 3,000 2,800 2,800
QRsP-2 8,200 8,800 8,700 8,800
QRsP-3 8,000 7,500 7,400 7,500
QRsP-4 6,600 6,800 6,800 6,800
'QR-32 cells and QRsP tumour lines were maintained under normal
culture conditions (See Materials and methods) for the indicated times.
bMicewereinjected s.c. with 2 x I05ofone orother type oftumourcell.
CPGE2-production during in vitro culture ofQR-32 and QRsP tumour
cells was measured by the same procedure as described in Table II-i.
significant differences were observed in their growth rates and
doubling times in culture.
Growth ofQR-32 cells after coimplantation with gelatin
sponge-reactive peritoneal cells
To investigate the role of host cells reactive to gelatin sponge
in the enhancement of in vivo s.c. tumorigenicity, we
harvested gelatin sponge-reactive peritoneal exudate cells
from mice which had been implanted with gelatin sponge.
After QR-32 cells (1 x 105) had been added to gelatin
sponge-reactive cells (either 1 x 10' or I x 106), cell mixtures
were injected s.c. into normal syngeneic mice (Table IV).
When QR-32 cells were coimplanted with 1 x l0' or 1 x 106
gelatin sponge-reactive cells, the respective QR-32 cells grew
progressively in two out of six animals (P<0.05) and five
out of 12 animals (P<0.01). In none of the groups tested
were any significant differences observed in the mean survival
times (MST) of the mice which died. As a negative control,
1 x 105 QR-32 cells alone were injected subcutaneously into
20 mice: no resultant tumours were observed. These observa-
tions suggest that for tumorigenicity of the QR-32 cells to be
increased, the same cells must be exposed to host cells re-
Table II Tumorigenicity and prostaglandin E2-production by QR-32 cells
and QRsP tumour lines
Tumorigenicity
Subcutaneous Intravenous PGE2-
injection injectione production'
(Died mice (No. ofcolonies (Mean ± s.d.,
CellS /mice used) per mouse lung) pgml')
QR-32 0/8 0,0,0,0,0,0,0,0,0,0,2 1,467 ± 115
QRsP-l 2/5b 20,32,34,85,88,77,115,164l 2,750 ± 433i
QRsP-2 5/5C > 150 x 8f 8,667 ± 416i
QRsP-3 3/5d > 150 x 8' 7,600 529'
QRsP-4 5/5C 0,10,27,29,62,69,77g 6,833 ± 208
aOne x 105 QR-32 cells were s.c. coimplanted with gelatin sponge into
normal mice. The resultant tumours were cultured separately and named
QRsP-l to QRsP-4. bCdNormal mice were injected s.c. with 2 x 105 cells of
either QRsP tumour cells or QR-32 cell. b; not significant, c; P<0.01, d;
P<0.05, versus animals injected s.c. with QR-32 cells. cIn a separate
experiment,micewerei.v. injectedwith 1 x 106ofeachofthefourtumourcell
types. 19dayslater, themiceweresacrificed andthemetastaticnoduleson the
lungsurfacewerecountedmicroscopically. Each valuerepresents thenumber
ofcolonies permouselung.fgf; P<0.001, g; P<0.05 versusanimalsinjected
i.v. with QR-32 cells. hPGE2 levels in supernatants obtained from 1 x 105
tumour cell cultures in 24-well plastic plates in 2 ml of medium for 24 h.
Determinations were carried out in triplicate and a mean and standard
deviation wasobtained. iJi; P<0.01,j; P<0.001 versusPGE2-production by
QR-32 cells alone.638 F. OKADA et al.
Table IV Growth of QR-32 cells after coimplantation with gelatin
sponge-reactive host cells
No. of No. ofgelatin Tumorigenicit/ MST of
QR-32 sponge-reactive dead
cells cellsa Died/used (%) micec
I x 105 1 X 105 2/6d (33) 54.5 ± 3.5
1 X 105 1 X 106 5/12C (42) 50.4 ± 12.2
1 X 105 0/20 (0) -
aNormal C57BL/6 mice were implanted with gelatin sponge into the
peritoneal cavity. Fivedayslater, peritoneal exudate cells werecollected
and seeded into plastic dishes in medium at 37°C for 1 h. Plastic
non-adherent cells were then collected and used as gelatin
sponge-reactive host cells. 61 x 105 QR-32 cells were mixed with or
without gelatin sponge-reactive host cells or normal PEC and injected
subcutaneously into normal mice. cMST; mean survival time in days,
(Mean ± s.d.). ded; P<0.05, e; P<0.01 versus animals injected with
QR-32 cells alone.
active to foreign bodies such as gelatin sponge, which coexist
at the site of tumour cell implantation, rather than requiring
direct contact with the gelatin sponge for anchorage.
Increasedproduction ofprostaglandin E2 by coculture of
QR-32 cells with gelatin sponge-reactive cells
We measured PGE2-production in the supernatants of cocul-
tures of QR-32 cells (1 x 104) and gelatin sponge-reactive
cells (1 x 106). After 24 and 48 h coculture, PGE2-production
increased markedly (Table V). Throughout the experiments,
the amount of PGE2 produced by QR-32 cells alone (1 x 104)
was lower than 1,400 pg ml-', while the PGE2 produced by
gelatin sponge-reactive cells (1 x 106) was lower than
1,300 pg ml-'. We have therefore speculated that the large
amount of PGE2 was produced mainly by tumour cells. This
speculation is further supported by the fact that QRsP
tumour lines produce large amounts of PGE2, even when
cultured alone in the absence of host reactive cells (Tables II
and III).
Inhibition ofthe increase in PGE2-production by QR-32 cells in
thepresence ofradical scavengers
We also examined the effect of radical scavengers on the
large amount of PGE2 produced by QR-32 cells cocultured
with gelatin sponge-reactive cells (Table VI). Superoxide dis-
mutase (SOD, 300 U ml-') did not inhibit the production of
PGE2 whereas catalase (20,000 U ml-'), mannitol (5 x
10-2 M) and SOD plus catalase completely inhibited PGE2-
production. As a positive control, marked inhibition of PGE2
synthesis was observed after the addition of the prostaglan-
din synthesis inhibitor, indomethacin (10-6M).
Discussion
In this study, we demonstrate that gelatin sponge facilitates
the growth of weakly tumorigenic QR-32 fibrosarcoma cells
in syngeneic mice. Moreover, QRsP tumour lines established
Table V Increased production of prostaglandin E2 by coculture of
QR-32 cells with gelatin sponge-reactive cells
No. of No. of PGE2-production during observation periodb
tumour reactive
cells cellsa 24 48 (hours)
I X 104 1 X106 13,500 ± 500 15,667 + 557
l X 104 1,383 ± 29 1,350 ± 50
- 1x 106 1,167± 115 947±61
aGelatin sponge-reactive cellswereobtained bythesameprocedureas
described in Table IV-a. "At 24 and 48 h, the coculture supernatants
were assayed for PGE2. Determinations were carried out in triplicate
and a mean and standard deviation was obtained (pg ml- ').
Table VI Inhibition ofincrease inPGE2-production byQR-32 cells in
the presence of radical scavengers
Treateda
with
No scavengers
SOD
Catalase
Mannitol
SOD + Catalase
Indomethacin
PGE2-production (pgml-') byb
QR-32 + gelatin Gelatin
sponge- sponge-
reactive QR-32 reactive
cells cells cells
8,000 580 1,900
9,200 300 1,600
620 <250 250
<250 <250 <250
380 <250 250
<250 <250 <250
aEach cell type (1 x 104 QR-32 cells and 1 x 106 gelatin
sponge-reactive cells) was plated into wells in a 24-well plastic plate in
2 ml of medium with or without oxygen radical scavengers; SOD
(300 U ml1), catalase (20,000 U ml'- ), mannitol (5 x 1O-2M) for48 h.
"PGE2-production after 48 h was measured by the same procedure as
described in Table II-i.
from the resultant tumours exhibited more malignant charac-
teristics as compared with parental QR-32 cells. We thus
suspected that gelatin sponge might promote the malignant
progression of tumour cells. As possible roles of the gelatin
sponge in the facilitation of tumour growth, we first con-
sidered that gelatin sponge might provide direct anchorage to
tumour cells in vivo; second, that the sponge induces host
reactive cells at the site of tumour implantation and that the
reactive cells promote the growth of tumour cells. The former
possibility is unlikely, however, because we found that it is
not necessary for the gelatin sponge to exist at the site of
tumour implantation for tumour progression to occur. In
fact, we observed that QR-32 cells were also able to grow in
normal mice when they were coimplanted with gelatin
sponge-reactive peritoneal exudate cells (PEC). It can be
concluded, therefore, that in our experimental model host
cells reactive to gelatin sponge are responsible for the facilita-
tion of the in vivo growth ofweakly tumorigenic QR-32 cells.
The rationale for using gelatin sponge in our experiments
includes the following two points: first, the gelatin sponge
induces the recruitment and accumulation of sufficient
numbers of host cells at tumour implantation sites (Hanto et
al., 1982; Akporiaye et al., 1987; Akporiaye & Kudalore,
1989), whilst eliciting relatively low responses in the host
(Carter, 1981; Jenkins et al., 1946) and second, gelatin
sponge is now widely used in antitumour surgery as a hemo-
static material and during chemoembolisation therapy in
patients with liver cancer (Shimamura et al., 1988; Sasaki et
al., 1987).
We believe that inflammatory processes might involve the
conversion of tumour cells into more malignant cells. This
hypothesis is partially supported by our in vitro experiments
in which we observed that the production of prostaglandin
E2 (PGE2) by tumour cells was increased after coculture with
host reactive cells. With regard to the role of PGE2-
production by QR-32 cells, we have previously reported that
large amounts of PGE2 inhibit T cell responses to tumour
cells and permit their growth as a result of escaping host
immunological surveillance (Okada et al., 1990). In the pre-
sent experiments, we have also observed that large amounts
of PGE2-production by QRsP tumour lines correlated well
with their in vivo tumorigenicity (Table II).
The emergence of progressor QRsP tumour lines might be
due to the pre-existence of progressor cells within the QR-32
tumour cell population which become dominant under ap-
propriate micro-environmental conditions, a process which is
generally termed in vivo selection pressure (Fidler & Kripke,
1977; Morikawa et al., 1988). Although the in vivo selection
pressure is likely to be one of the mechanisms responsible for
the emergence of progressor tumour cells even in our
experiments, we also consider that another possibility involv-
ing host reactive cell or their products may increase tumour
malignancy through the induction of mutations in tumourMALIGNANT TUMOUR PROGRESSION BY HOST REACTIVE CELLS 639
cells by producing oxygen radicals. This consideration was
raised by two of our own observations. First, QR-32 cells
were obtained from cloned tumour variants (Ishikawa et al.,
1987a; Okada et al., 1990). Secondly, when we obtained
subclones from the cloned QR-32 cells, all 14 of the sub-
clones spontaneously regressed when implanted into normal
mice and the levels of PGE2-production by these subclones
were low and in the same range as those produced by the
parental QR-32 cells (manuscript in preparation). We are
now investigating whether host reactive cells are easily able
to induce mutations in QR-32 cells as detected by specific
minisatellite probes (Pc-i) for the detection of mutations-in
DNA fingerprinting. Such hypotheses are also supported by
other results, obtained for different tumour and reactive cell
systems (Yamashima et al., 1986; Loveless & Heppner, 1983;
Fulton et al., 1984; 1988).
In the present experiments, active radicals produced by
host cells reactive to gelatin sponge may be involved in the
malignant conversion of tumour cells. We are presently at-
tempting to confirm the direct production of active radicals
by gelatin sponge-reactive cells and the mechanism of
involvement of the former in tumour progression.
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